ConforMIS Inc. (NASDAQ:CFMS) – Equities research analysts at SunTrust Banks issued their Q3 2016 EPS estimates for ConforMIS in a research note issued to investors on Monday. SunTrust Banks analyst B. Nudell anticipates that the brokerage will post earnings per share of ($0.34) for the quarter. SunTrust Banks has a “Buy” rating and a $14.00 price target on the stock. SunTrust Banks also issued estimates for ConforMIS’s Q4 2016 earnings at ($0.30) EPS, FY2016 earnings at ($1.35) EPS, Q1 2017 earnings at ($0.37) EPS, Q2 2017 earnings at ($0.35) EPS, Q3 2017 earnings at ($0.29) EPS, Q4 2017 earnings at ($0.22) EPS, FY2017 earnings at ($1.20) EPS, FY2018 earnings at ($0.99) EPS, FY2019 earnings at ($0.84) EPS and FY2020 earnings at ($0.55) EPS.

Other equities analysts have also issued reports about the company. B. Riley began coverage on ConforMIS in a research report on Wednesday. They issued a “buy” rating and a $13.00 target price on the stock. Oppenheimer Holdings Inc. upped their target price on ConforMIS from $12.00 to $13.00 and gave the company an “outperform” rating in a research report on Tuesday, August 9th. Zacks Investment Research lowered ConforMIS from a “hold” rating to a “sell” rating in a research report on Tuesday, June 7th. Finally, JPMorgan Chase & Co. cut their target price on ConforMIS from $11.00 to $8.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 9th. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. ConforMIS currently has a consensus rating of “Buy” and an average price target of $14.86.

Shares of ConforMIS (NASDAQ:CFMS) traded down 2.3121% during midday trading on Wednesday, hitting $9.2022. 87,274 shares of the company’s stock traded hands. The stock’s market cap is $387.66 million. The company has a 50 day moving average of $8.22 and a 200 day moving average of $8.80. ConforMIS has a 52 week low of $4.80 and a 52 week high of $23.62.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/conformis-inc-cfms-to-post-q3-2016-earnings-of-0-34-per-share-suntrust-banks-forecasts.html

ConforMIS (NASDAQ:CFMS) last issued its earnings results on Monday, August 8th. The company reported ($0.34) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.01. The company had revenue of $19.30 million for the quarter, compared to analyst estimates of $18.02 million. ConforMIS had a negative net margin of 84.33% and a negative return on equity of 45.30%. The business’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm earned ($2.51) EPS.

A number of large investors have recently modified their holdings of the company. BlackRock Institutional Trust Company N.A. boosted its position in ConforMIS by 0.9% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 272,339 shares of the company’s stock valued at $2,928,000 after buying an additional 2,347 shares during the last quarter. Geode Capital Management LLC boosted its position in ConforMIS by 15.1% in the first quarter. Geode Capital Management LLC now owns 77,877 shares of the company’s stock valued at $837,000 after buying an additional 10,235 shares during the last quarter. LPL Financial LLC acquired a new position in ConforMIS during the first quarter valued at about $145,000. American International Group Inc. boosted its position in ConforMIS by 242.6% in the second quarter. American International Group Inc. now owns 20,584 shares of the company’s stock valued at $144,000 after buying an additional 14,575 shares during the last quarter. Finally, Raymond James & Associates acquired a new position in ConforMIS during the second quarter valued at about $113,000. 41.38% of the stock is currently owned by hedge funds and other institutional investors.

In other ConforMIS news, insider Daniel Steines sold 30,000 shares of the stock in a transaction on Friday, September 16th. The stock was sold at an average price of $9.09, for a total value of $272,700.00. Following the sale, the insider now directly owns 245,213 shares of the company’s stock, valued at $2,228,986.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Kenneth P. Fallon III sold 4,000 shares of the stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $8.44, for a total value of $33,760.00. Following the completion of the sale, the director now directly owns 92,222 shares in the company, valued at $778,353.68. The disclosure for this sale can be found here. 9.20% of the stock is owned by company insiders.

ConforMIS Company Profile

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

5 Day Chart for NASDAQ:CFMS

Receive News & Ratings for ConforMIS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConforMIS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.